SAPIENT CAPITAL LLC

Position in INTS — Intensity Therapeutics, Inc.

CIK 1998653 INDIANAPOLIS, IN

Position in INTS

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$106,624

-$46,291 QoQ

Shares Held

26,006

0.0% QoQ

Ownership

0.797%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 16 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SAPIENT CAPITAL LLC holds $34,121,163 across 5 Biotechnology names. INTS ranks #5 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	92,162	$24,581,448
2	VRTX	Vertex Pharmaceuticals Inc / Ma	18,011	$8,946,604
3	EXEL	Exelixis, Inc.	5,658	$307,851
4	NUVB	Nuvation Bio Inc.	31,450	$178,636
5	INTS	Intensity Therapeutics, Inc. This page	26,006	$106,624

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$106,624	26,006	0.0%	Shares	Sole	2026-07-09
2026-03-31	$152,915	26,006	-96.0%	Shares	Sole	2026-04-08
2025-12-31	$266,561	650,151	-33.4%	Shares	Sole	2026-02-05
2025-09-30	$237,361	976,797	0.0%	Shares	Sole	2025-10-17
2025-06-30	$299,876	976,797	0.0%	Shares	Sole	2025-07-09
2025-03-31	$1,924,290	976,797	+3.6%	Shares	Sole	2025-04-15
2024-12-31	$1,659,400	942,841	-6.7%	Shares	Sole	2025-01-29
2024-09-30	$3,861,076	1,010,753	0.0%	Shares	Sole	2024-10-11
2024-06-30	$4,952,689	1,010,753	-0.1%	Shares	Sole	2024-07-15
2024-03-31	$5,262,758	1,012,069	+406.0%	Shares	Sole	2024-04-22
2023-12-31	$1,714,000	200,000	—	Shares	Sole	2024-02-06
No filing history on record for this holder in this stock.